Mechanism of Feiweikang granules in the treatment of COVID-19-related pulmonary fibrosis based on network pharmacology and molecular docking

YANG Fan; LI Wanyang; CAO Renshuang; BI Zhangyang; ZHANG Wei

doi:10.3969/j.issn.1002-266X.2020.23.002

Home>Articles>Mechanism of Feiweikang granules in the treatment of COVID-19-related pulmonary fibrosis based on network pharmacology and molecular docking

DOI: 10.3969/j.issn.1002-266X.2020.23.002

Mechanism of Feiweikang granules in the treatment of COVID-19-related pulmonary fibrosis based on network pharmacology and molecular docking

YANG Fan

LI Wanyang

CAO Renshuang

BI Zhangyang

ZHANG Wei

Machine-generated Keywords：

Publication Date：2020-08-15

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 6-10 )

Shandong Medical Journal

PKUISTIC

ISSN：1002-266X

Year, Vol.(Issue)：2020,60(23)